SERUM OSTEOPROTEGERIN FOR EARLY IDENTIFICATION OF CAD IN TYPE 2 DM PATIENTS. IJeR [Internet]. 2025 Jun. 7 [cited 2026 May 18];2(3):20-5. Available from: https://ijeres.org/index.php/ijer/article/view/10